• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

BFH-772

CAS No. 890128-81-1

BFH-772 ( BFH772;BFH 772 )

产品货号. M16425 CAS No. 890128-81-1

A potent, selective and orally active VEGFR2 tyrosine kinase inhibitor with IC50 of 3 nM.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥308 有现货
5MG ¥486 有现货
10MG ¥851 有现货
25MG ¥1604 有现货
50MG ¥2406 有现货
100MG ¥4560 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    BFH-772
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A potent, selective and orally active VEGFR2 tyrosine kinase inhibitor with IC50 of 3 nM.
  • 产品描述
    A potent, selective and orally active VEGFR2 tyrosine kinase inhibitor with IC50 of 3 nM; shows 40-fold less potent activity B-RAF, RET and TIE-2, and >500-fold for FLK-1, FLT-1 and FLT-4; inhibits ligand-induced autophosphorylation of RET, PDGFR and KIT with IC50 of 30-160 nM, potently inhibits VEGF-driven angiogenesis in a chamber model and rodent tumor models at daily doses of less than 3 mg/kg.Psoriasis Phase 2 Discontinued
  • 同义词
    BFH772;BFH 772
  • 通路
    Angiogenesis
  • 靶点
    VEGFR
  • 受体
    VEGFR2
  • 研究领域
    Inflammation/Immunology
  • 适应症
    Psoriasis

化学信息

  • CAS Number
    890128-81-1
  • 分子量
    439.39
  • 分子式
    C23H16F3N3O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: 7.75 mg/mL
  • SMILES
    O=C(C1=C2C=CC(OC3=NC=NC(CO)=C3)=CC2=CC=C1)NC4=CC=CC(C(F)(F)F)=C4
  • 化学全称
    1-Naphthalenecarboxamide, 6-[[6-(hydroxymethyl)-4-pyrimidinyl]oxy]-N-[3-(trifluoromethyl)phenyl]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Bold G, et al. J Med Chem. 2016 Jan 14;59(1):132-46.
产品手册
关联产品
  • TAS-115

    TAS-115 is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).

  • Asimadoline hydrochl...

    Asimadoline HCl is a κ-opioid receptor agonist potentially for the treatment of pruritus. Asimadoline has also been shown to be used in the treatment of irritable bowel syndrome.

  • UNC0064-12 hydrochlo...

    UNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.